PVLA — Palvella Therapeutics, Inc.

PVLAPalvella Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · palvellatx.com

112.60USD-3.58%Mkt Cap: 1.63B USDP/E: —Last update: 2026-06-01

Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. The company's lead product cand…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap1.63B USD

Enterprise Value1.46B USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-41.72M USD

Revenue/Share—

Last Price112.60 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees29

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-17.73

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B7.30

EPS (TTM)-4.18

EPS (Forward)-6.68

52W Range

20.2071% of range151.18

52W High151.18 USD

52W Low20.20 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-149.07%

ROA-70.04%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-25.01M USD

CapEx (TTM)—

FCF Margin—

FCF Yield-1.33%

Net Debt-241.47M USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.02

Current Ratio28.88

Quick Ratio28.73

Book Value/Sh16.23 USD

Cash/Share18.26 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:80

Split DateApr 23, 2024

Analyst Consensus

Rating1.0 (Strong Buy)

Target (Mean)229.56 USD

Target Range205.00 USD – 270.00 USD

# Analysts16

Ownership

Shares Out.14.34M

Float9.58M

Insiders11.65%

Institutions95.97%

Short Interest

Short Ratio9.7d

Short % Float16.95%

Short % Out.14.97%

Shares Short2.15M

Short (prev mo.)1.98M

Technical

SMA 50121.43 (-7.3%)

SMA 20093.19 (+20.8%)

Beta—

S&P 52W Chg27.70%

Avg Vol (30d)196.75K

Avg Vol (10d)181.99K

Technical Indicators

RSI (14)47.5

MACD-2.2865

MACD Signal-2.3255

MACD Hist.+0.0390

BB Upper132.18 USD

BB Middle118.76 USD

BB Lower105.34 USD

BB Width22.60%

ATR (14)6.486 USD

Vol Ratio (20d)0.41x